" class="no-js "lang="en-US"> Juan Andres - Medtech Alert
Saturday, December 14, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Juan Andres

Juan Andres

About Juan Andres

29 years of profesional experience in US, Spain, UK and Switzerland at Lilly, Novartis and Moderna Tx. Executive positions for last 15 years with responsibility over overall Q Unit, Technical Development and all Manufacturing operations as last three positions prior to current one. Exceptional results overseeing organizations worldwide and multibillion $ budgets.

Related Story

Industry News

 Moderna and Thermo Fisher Scientific Announce Long-term Strategic Collaboration | Pharmtech Focus

Moderna and Thermo Fisher Scientific Announce Long-term Strategic Collaboration

February 24 2022

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and […]

COVID-19

 Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline | Pharmtech Focus

Moderna and Aldevron Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline

May 24 2021

Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the […]